,,,,
By using this website you allow us to place cookies on your computer. Please read our Privacy Policy for more details.
Publication Date: February 2008
Publisher: Mathematica Policy Research, Inc.
Author(s): Arnold Chen; Randall Brown; Dominick Esposito; Jennifer Schore; Rachel Shapiro
Research Area: Health
Keywords: Prescription Drug Benefit; Fee-for-Service; Medicare; Disease Management
Type: Report
Abstract:
Before Medicare Part D, Congress authorized the Medicare disease management demonstration to evaluate whether disease management programs--in conjunction with a comprehensive prescription drug benefit--could improve health outcomes and reduce Medicare expenditures. The demonstration targeted fee-for-service Medicare beneficiaries with advanced congestive heart failure, diabetes, or coronary artery disease. This congressionally mandated study found that, based on the population-based random assignment design, none of the three demonstration programs had impacts on key outcomes of Medicare Part A and B expenditures and service use.